| Summary: | Objective:To determine the change in opinion about the treatment options of Turkish doctors who fight Coronavirus (COVID) in 2nd and 3rd level hospitals.Method:A questionnary compromised of 14 questions is asked to clinicians who worked in COVID clinics of 2nd and 3rd level hospitals in March 2021 and March 2022.Results:Prednisolone, IV use of 60 and 80 mg when added to standart therapies was observed more effective in 2022 than in 2021. Also, use of high doses of prednisolone (250 mg and higher) was also found more efective in 2022 than 2021. Acetyl salicilic acide (ASA) is used in routine treatment in both years, but there was a small decline of trust level in its effectiveness in 2022 than in 2021. Low molecular weight heparine, (especially enoxaparine) is also used in the treatment of COVID for both years and a relatively small decline of trust in its effectiveness was observed in 2022 than in 2021. For vaccines, use of BIONTECH was the golden choice of clinicians for themselves and to be used for their relatives.Conclusion:During the pandemic, clinicians tried to find the right treatment option to gain control over COVID, at the end ofalmost 3 years, it is well understood that there was no specific treatment but vaccines, steroids, ASA, low molecular weight heparin were the best agents to be used to help COVID patients not to decline to more severe conditions. In Turkey, after our study we can conclude that Turkish clinicians used the similar treatment options and vaccines as their global colleagues and found those agents effective than the other options.
|
|---|